CannTrust Statement Regarding Notice of Product Return at Ontario Cannabis Store

VAUGHAN, ON, Aug. 19, 2019 /CNW/ – CannTrust Holdings Inc. (“CannTrust” or the “Company”,TSX: TRST, NYSE: CTST) has received a notice from the Ontario Cannabis Store (the “OCS”), the Crown corporation in charge of wholesale distribution of cannabis products to licensed cannabis retailers in Ontario and the operator of Ontario’s online recreational cannabis store, advising the Company that the OCS has determined certain of the Company’s products sold to the OCS are Non-Conforming Products under the terms of the Master Cannabis Supply Agreement between the Company and the OCS (the “Master Agreement”) and that the OCS has elected to return these products to the Company.  Under the terms of the Master Agreement, any product that does not comply with applicable law is considered to be Non-Conforming Product and the OCS may elect to exercise its right, among others, to return such product to the Company at the Company’s expense.

The products listed in the OCS return notice constitute all or substantially all of the Company’s products currently held at the OCS and are valued at approximately $2.9 million in the aggregate.  The Company intends to fully perform its obligations under the Master Agreement.  The OCS operates independently of Health Canada.  Health Canada has not ordered a recall in respect of any of the Company’s products.

About CannTrust

CannTrust is a federally regulated licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, CannTrust brings years of pharmaceutical and healthcare experience to the medical cannabis industry and serves medical patients with its dried, extract and capsule products. The Company operates its Niagara Perpetual Harvest Facility in Pelham, Ontario, and prepares and packages its product portfolio at its manufacturing centre in Vaughan, Ontario. The Company has also purchased 81 acres of land in British Columbia and expects to secure over 240 acres of land in total for low-cost outdoor cultivation which it will use for its extraction-based products.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of Canadian Securities laws and “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable United States safe harbor laws, and such statements are based upon CannTrust’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information and forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

The forward-looking information and statements in this news release include statements relating to the return of the Company’s products, the Company’s performance under the Master Agreement, the corrective actions being taken by the Company, and Health Canada’s pending determinations. Forward-looking information and statements necessarily involve known and unknown risks, including, without limitation: actions taken in respect of the Company’s products by its customers and regulators; results of Health Canada’s investigation, including orders and compliance measures required by Health Canada and their impact on the operations, inventory, assets and financial condition of the Company; the Company’s implementation of remediation plans and related actions; regulatory approval; risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States and elsewhere; the cannabis industry in Canada generally; and, the ability of CannTrust to implement its business strategies.

Any forward-looking information and statements speak only as of the date on which they are made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking information and statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust’s Annual Information Form dated March 28, 2019 (the “AIF”) and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and filed as an exhibit CannTrust’s Form 40-F annual report under the United States Securities Exchange Act of 1934, as amended, with the United States Securities and Exchange Commission on EDGAR at www.sec.gov. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information or statements.

The TSX and NYSE do not accept responsibility for the adequacy or accuracy of this release.

SOURCE CannTrust Holdings Inc.

Related Links

https://www.canntrust.ca/

By OCN Media News

OnlyCannabisNews scours the web and brings you the latest and most important cannabis related news across a variety of categories. OnlyCannabisNews focuses on reporting and promoting the stories of people and organizations in the world of cannabis.

Last Updated August 19, 2019

..
..
Related Stories
Charlotte’s Web Launches Pet Chew for Dogs with Sensitive Skin

Charlotte’s Web Launches Pet Chew for Dogs with Sensitive Skin

Charlotte's Web™ Skin Health & Allergy Support Chews are chicken flavored and come in 30-count ($19.99 SRP) and 60-count ($34.99 SRP) sizes and are non-GMO and grain-free. Like all Charlotte's Web products, all pet SKUs are tested 20+ times from seed to shelf for...

Aurora Announces Manufacturing Agreement with The Valens Company

Aurora Announces Manufacturing Agreement with The Valens Company

New Seasonal Offerings Slated for November Release  EDMONTON, AB, Oct. 28, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a manufacturing...

OCN Exclusive content
Shantal Arroyo: Clinique La Croix Verte

Shantal Arroyo: Clinique La Croix Verte

Who: Shantal Arroyo Title: Co-founder Organization: Clinique La Croix Verte Facebook Page Corporate SitePour lire cet article en français, veuillez suivre ce lien.Introduction to Shantal Arroyo Shantal Arroyo is the founder of Clinique La Croix Verte, a medical...

Shantal Arroyo: Clinique La Croix Verte (français)

Shantal Arroyo: Clinique La Croix Verte (français)

Qui: Shantal Arroyo Titre: Co-fondatrice Organization: Clinique La Croix Verte Page Facebook Site CorporatifTo read this article in English, please follow this link.Présentation de Shantal Arroyo   Shantal Arroyo est la fondatrice de la Clinique La Croix Verte,...

James Williams: Cannabis Manufacturer’s Guild

James Williams: Cannabis Manufacturer’s Guild

Who: James Williams Title: Co-founder Company: Cannabis Manufacturer's Guild Company LinkedIn Profile Company WebsiteIntroduction to James Williams OnlyCannabisNews was given the opportunity to interview James Williams of the Cannabis Manufacturer's Guild. James...